Remove Artificial Inteligence Remove Blogging Remove San Diego Remove Venture Capital
article thumbnail

San Diego Roundup: Qualcomm, Philter, Stella Labs, VC Funding & More

Xconomy

Let’s catch up with the latest tech news in San Diego. —San Diego’s AON Devices was among 10 startups selected to compete at a recent pitch competition hosted by the corporate venture capital arm of Qualcomm (NASDAQ: QCOM ). Read more » Reprints | Share:

article thumbnail

What’s the Business Model for Artificial Intelligence in Healthcare?

Xconomy

These are heady times for using artificial intelligence to extract insights from healthcare data—in particular, from the tidal wave of information coming out of fields like genomics and medical imaging. This story is part of an ongoing Xconomy series on A.I. in healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Some of the Best Reads for Casual Friday: Artificial Intelligence

Xconomy

This week, we’re focusing on artificial intelligence, one of the buzziest fields in tech. Or, maybe instead, it’s a day filled with long lunches and listless Internet surfing, as you seek out all the interesting articles you missed during the week. Here are a. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

article thumbnail

San Diego VC Funding at $426.6M in Third Quarter; Plus Top 10 Deals

Xconomy

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. As Xconomy reported in July, Brain Corp.

article thumbnail

Nervana’s $400M+ Buyout Reflects Key Tech Trend in Machine Learning

Xconomy

On the day after Intel announced its acquisition of San Diego machine learning startup Nervana Systems, investor Steve Jurvetson told me he was feeling a sense of satisfaction about a call he made three years ago, and how it has been playing out.

article thumbnail

Ada-AI Seeks to Build a Diverse Artificial Intelligence Community

Xconomy

Artificial intelligence innovation has become part of our everyday lives—retailers use it to tailor the product recommendations they make; biotech companies hope it can create customized medicine. But its shortcomings, born of human biases, are becoming apparent as well.

article thumbnail

Five Questions With a16z’s Vijay Pande on AI and Making New Drugs

Xconomy

Those tools—artificial intelligence and machine learning, respectively—have been around for decades, but in recent years have become faster and cheaper, accelerating their use by those in the business of discovering and developing new drugs.